Neurontin and Vascular compression - a phase IV clinical study of FDA data

Summary:

Vascular compression is reported as a side effect among people who take Neurontin (gabapentin), especially for people who are male, 50-59 old, also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Vascular compression when taking Neurontin. It is created by eHealthMe based on reports of 103,969 people who have side effects when taking Neurontin from the FDA, and is updated regularly.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

What is Vascular compression?

Vascular compression is found to be associated with 101 drugs and 107 conditions by eHealthMe. Check the latest studies of Vascular compression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

103,969 people reported to have side effects when taking Neurontin.
Among them, 12 people (0.01%) have Vascular compression.

Could Neurontin cause Vascular compression?

Among these 12 people:

What is the gender of people who have Vascular compression when taking Neurontin? *

female: 0.0 %
male: 100 %

What is the age of people who have Vascular compression when taking Neurontin? *

What are other drugs people take besides Neurontin? *

What are other side effects people have besides Vascular compression? *

Cellulitis (infection under the skin): 12 people, 100.00%
Oedema (fluid collection in tissue): 12 people, 100.00%
Hypotension (abnormally low blood pressure): 12 people, 100.00%
Oedema Peripheral (superficial swelling): 11 people, 91.67%
Hypokalemia (low potassium): 11 people, 91.67%
Injury: 9 people, 75.00%
Headache (pain in head): 9 people, 75.00%
Hearing Loss: 9 people, 75.00%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 75.00%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 75.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 75.00%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 3 people, 25.00%
Muscle Spasms (muscle contraction): 3 people, 25.00%
Dizziness: 3 people, 25.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 25.00%
Autonomic Failure Syndrome (a degenerative disease of the autonomic nervous system): 3 people, 25.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 25.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Vascular compression?

- Check whether Vascular compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neurontin:

Neurontin (107,468 reports)

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vascular compression:

Vascular compression (101 drugs)

Browse all the conditions that are associated with Vascular compression:

Vascular compression (107 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.